Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.

A new Medicare GLP-1 Bridge program offers Wegovy and Zepbound to eligible seniors for $50 a month starting July 1, slashing ...

Medicare GLP-1 Bridge provides Wegovy to eligible beneficiaries for $50/month through 2027, creating a defined access channel for obesity treatment previously largely excluded from Medicare coverage.

CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.

Millions of Medicare beneficiaries could soon pay significantly less for popular GLP-1 weight loss medications under a new ...

Once they reach age 65, people qualify for Original Medicare Part A. They can also enroll in Original Medicare Part B, Part D prescription drug plans, and Medigap supplement insurance. Medicare Part A ...

Medicare covers a lot. It does not cover everything — and the gaps it leaves are among the most expensive surprises a retiree ...

Instituting a cap on Medicare out-of-pocket expenses would likely help limit financial toxicity experienced by patients and ...